drugset / Trial / NCT01051232

A Study To Investigate Safety And Pharmacokinetics Of A Single Dose Of PF-00868554 (Filibuvir) In Japanese Healthy Adult Volunteers

NCT01051232

Phase 1 Completed 24 enrolled Pfizer
RandomizedParallel-groupTriple-blind

Summary

A single dose of PF-00868554 (filibuvir) will be safety and tolerable in Japanese healthy volunteers. The pharmacokinetics in Japanese will be consistent to that available in Western population.

Timeline

Start
2010-02
Primary completion
2010-04
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Filibuvir Small molecule 100 mg Oral
Comparator Filibuvir Small molecule 300 mg Oral
Comparator Filibuvir Small molecule 500 mg Oral

Indications

No indication recorded.